Fonseca R - Search Results

1

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma.

Lonial S, Jacobus S, Fonseca R, Weiss M, Kumar S, Orlowski RZ, Kaufman JL, Yacoub AM, Buadi FK, O'Brien T, Matous JV, Anderson DM, Emmons RV, Mahindra A, Wagner LI, Dhodapkar MV, Rajkumar SV. Lonial S, et al. Among authors: fonseca r. J Clin Oncol. 2020 Apr 10;38(11):1126-1137. doi: 10.1200/JCO.19.01740. Epub 2019 Oct 25. J Clin Oncol. 2020. PMID: 31652094 Free PMC article. Clinical Trial.

2

Anemia after orchiectomy.

Fonseca R, Rajkumar SV, White WL, Tefferi A, Hoagland HC. Fonseca R, et al. Am J Hematol. 1998 Nov;59(3):230-3. doi: 10.1002/(sici)1096-8652(199811)59:3<230::aid-ajh8>3.0.co;2-2. Am J Hematol. 1998. PMID: 9798661 Free article.

3

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: fonseca r. Leukemia. 1999 Mar;13(3):469-72. doi: 10.1038/sj.leu.2401336. Leukemia. 1999. PMID: 10086738

4

Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Therneau TM, Kyle RA, Litzow MR, Gertz MA, Greipp PR. Rajkumar SV, et al. Among authors: fonseca r. J Clin Oncol. 1999 May;17(5):1551-7. doi: 10.1200/JCO.1999.17.5.1551. J Clin Oncol. 1999. PMID: 10334543

5

Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Rajkumar SV, et al. Among authors: fonseca r. Bone Marrow Transplant. 1999 Jun;23(12):1261-6. doi: 10.1038/sj.bmt.1701787. Bone Marrow Transplant. 1999. PMID: 10414913 Clinical Trial.

6

Autologous stem cell transplantation for relapsed and primary refractory myeloma.

Rajkumar SV, Fonseca R, Lacy MQ, Witzig TE, Lust JA, Greipp PR, Therneau TM, Kyle RA, Litzow MR, Gertz MA. Rajkumar SV, et al. Among authors: fonseca r. Bone Marrow Transplant. 1999 Jun;23(12):1267-72. doi: 10.1038/sj.bmt.1701805. Bone Marrow Transplant. 1999. PMID: 10414914 Clinical Trial.

7

Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.

Rajkumar SV, Fonseca R, Dewald GW, Therneau TM, Lacy MQ, Kyle RA, Greipp PR, Gertz MA. Rajkumar SV, et al. Among authors: fonseca r. Cancer Genet Cytogenet. 1999 Aug;113(1):73-7. doi: 10.1016/s0165-4608(99)00009-6. Cancer Genet Cytogenet. 1999. PMID: 10459351

8

Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.

Rajkumar S, Fonseca R, Lacy M, Witzig T, Lust J, Greipp P, Therneau T, Kyle R, Litzow M, Gertz M. Rajkumar S, et al. Among authors: fonseca r. Bone Marrow Transplant. 1999 Sep;24(5):497-503. doi: 10.1038/sj.bmt.1701943. Bone Marrow Transplant. 1999. PMID: 10482933

9

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

10

Waldenström's macroglobulinemia.

Gertz MA, Fonseca R, Rajkumar SV. Gertz MA, et al. Among authors: fonseca r. Oncologist. 2000;5(1):63-7. doi: 10.1634/theoncologist.5-1-63. Oncologist. 2000. PMID: 10706651 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,437 results

Search Page